Thursdays Watchlist - FFGO, CAGI, GMPM

FFGO is a lotto play everyone loves to hate. They issue amazing forward looking press releases that gets investors foaming at the mouth. More often than not the price of the stock sees a pop, I think that holds true for FFGO again with today's press. It is a Guru Buy with money you can afford to lose.

CAGI again saw record volume and the stock languished to finish just barely green. Something continues to hold this stock back. If it is indeed shorting than this stock will see some significant buying the next few trading sessions.

GMPM was up over 100% on the news pasted below. Let's see if there is any follow through to today's rally.


Gamma Pharmaceuticals Announces Multi-Year Distribution Agreement With Approximately $48 Million Annualized Minimum Sales Volume
LAS VEGAS, NV, Mar 03, 2010 (MARKETWIRE via COMTEX) -- Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM): Gamma Pharmaceuticals, Inc. ("Gamma" or the "Company") announced that it has entered into a multi-year agreement (the "Agreement") with one of North America's leading wholesale distribution organizations to distribute the full line of Gamma products. The Agreement, which is evergreen in duration, provides for minimum monthly volume purchases of Gamma products at agreed upon pricing per SKU. The contracted terms cover the sale of 40,000 cases per month of Gamma's branded products, which at full distribution equates to an annualized value of approximately $48.0 million. Gamma's new distribution partner is one of the largest wholesale distributors of branded consumer products in North America, and is credited with the enormous commercial success of many leading consumer brands.

Peter Cunningham, Gamma's Chief Executive Officer, commented on the agreement, "We are extremely pleased to have successfully contracted with such an accomplished distributor. The distributor and its retail network share Gamma's view that our products have great commercial appeal. This guarantee arrangement takes Gamma from the pre-revenue, pre-EBITDA company it has been over the past two years to a company with approximately $48 million in minimum annualized revenues, and enables Gamma's management and shareholders to look forward with more certainty in anticipating our growth and profitability." Mr. Cunningham added, "Gamma now has in place a distribution platform that truly complements the Company's product portfolio. Gamma can now successfully extend its commercial reach to more effectively attract additional retail accounts that will drive revenues in the US market for years to come."

About Gamma Pharmaceuticals, Inc.

Gamma Pharmaceuticals, Inc. (www.gammapharma.com) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in the United States and Greater China. Branded nutritional supplements are sold under the trademarks Brilliant Choice(TM) children's nutritional supplements featuring the call to action "Mom you've made a brilliant choice for your children's nutrition;" SAVVY(TM) adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy;" and, Jugular Energy Products(TM) and high performance supplements featuring the call to action, "Go for the Jugular(TM)." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology(R)," to create innovative gel product forms; that are designed to give consumers a more pleasant experience. Gel Delivery Technology(R) characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKUs and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact:
Gamma Pharmaceuticals, Inc.
Joe Cunningham
CFO
(jcunningham@gammapharma.com)
Direct: (651) 204 2048
Office: (702) 989 5262

Stocks To Watch Wednesday - CAGI, KNOS, NSFE

CAGI with over 58% of today's action shorting, one has to wonder what a little more buying pressure will bring. As I have noted in the past, Pink Sheet market makers feel they can short any stock with nary a risk of being caught with their pants down.... at least until they shorted VCTY. CAGI may provide the same type of scenario for anyone short this stock.

KNOS still remains a stock to watch going forward. I feel it will be trading higher than these prices down the road.

NSFE was up significantly today. This stock looks poised for more gains tomorrow. Rumors circulating about a new company coming into the shell.

CAGI - Getting The SHORT End Of The Stick

CAGI experienced record volume today and the price of the stock went.... down?  It makes you wonder why, as there has been no obvious selling of the issue until today.

The answer to who was selling came from a Guru Member who discovered that over 58% of the trades today were short sales, and knowing how these unscrupulous market makers work, these shares are most likely phantom shares.  It has to be nice to be able to make something out of thin air and sell it.  The problem with selling something you don't own, is what do you do when you have to buy it back for a substantially higher price?

Market makers who shorted VCTY should be able to answer that question.  Those market makers were shorting VCTY to no end at $.0013 to $.003.  Guess where they had to cover their ill-advised short positions?  I'll give a hint... VCTY hit $.0265 a share.

CAGI has a very tight share structure.  The stock has recently been reactivated as the gold bugs have come out of the woodwork.  CAGI is looking to capitalize on this.  Their recent press is pasted below for your reading pleasure.

When CAGI was actively traded it exchanged hands at over $.03 a share.  With some new found interest and some market maker covering this stock could be heading higher from today's $.0012 close.  Keep it on your radar.

CA Goldfields corporate update
TORONTO, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX/ -- CA Goldfields Inc. (OTC:CAGI.PK) is pleased to announce that it is revisiting its opportunity in the La Curva property in Nicaragua due to the recent high gold prices and maintained low extraction costs of mining in the area. This property known as "La Curva" borders the "Hemco Nicaraguan Concession", which has been a profitable gold producer for years. La Curva has never been exploited commercially but artisanan diggings performed by local miners indicate superficial gold deposits in various areas of the property. Existing assay results for the District of Bonanza indicate that 60% of all its land area contains economically exploitable gold reserves.
The property has a terrestrial expansion of approximately 2,000 acres and is located in Bonanza, a mining district that forms part of the world famous Golden Triangle of Nicaragua. The District of Bonanza has been a major contributor to the gold production in Nicaragua.
Gold prices will hit $1,500 an ounce in 2011 when oil prices move back above $100 a barrel as emerging market growth creates shortages, Bank of America Merrill Lynch said recently.
Jim Rogers, a famed investor known for his bullish calls on commodities, said recently that gold prices could top $2,000 an ounce within a decade. Investors will buy gold as a protection against a weaker U.S. dollar, he said
CA Goldfields currently has 237,000,000 shares outstanding . The transfer agent is Transfer Online of Portland, Oregon.
This press release contains "forward looking" statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward-looking statements as a result of risk factors discussed in New Wave Media Inc. reports that will be on file with the US Securities and Exchange Commission.
www.cagoldfields.com
SOURCE CA Goldfields Inc